Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibody

Author： Mayer A.   Chester K.A.   Bhatia J.   Pedley R.B.   Read D.A.   Boxer G.M.   Begent R.H.J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.7, 1998-06, pp. : 968-976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma

By Bilusic Marijo   Heery Christopher   Arlen Philip   Rauckhorst Myrna   Apelian David   Tsang Kwong   Tucker Jo   Jochems Caroline   Schlom Jeffrey   Gulley James   Madan Ravi  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 3, 2014-03 ,pp. : 225-234

Springer Publishing Company

Access to resources Recommend Favorite

Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy

By Deshane J.   Siegal G.P.   Wang M.   Wright M.   Bucy R.P.   Alvarez R.D.   Curiel D.T.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 378-385

Elsevier

Access to resources Recommend Favorite

Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010

By Marshall E.   Howell A.H.   Powles R.   Hunter M.G.   Edwards M.   Wood L.M.   Czaplewski L.   Puttick R.   Warrington S.   Boyce M.   Testa N.   Dexter T.M.   Lord B.I.   Millar A.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1023-1029

Elsevier

Access to resources Recommend Favorite

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

By Arnoletti J.   Frolov A.   Eloubeidi M.   Keene K.   Posey J.   Wood T.   Greeno Edward   Jhala N.   Varadarajulu S.   Russo S.   Christein J.   Oster R.   Buchsbaum D.   Vickers S.  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

By Sebastian Martin   Passlick Bernward   Friccius-Quecke Hilke   Jäger Michael   Lindhofer Horst   Kanniess Frank   Wiewrodt Rainer   Thiel Eckhard   Buhl Roland   Schmittel Alexander  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1637-1644

Springer Publishing Company

Access to resources Recommend Favorite